These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 6391928

  • 21. Enteric coated naproxen; a double blind trial comparing the tolerance of enteric coated and standard formulations.
    Huskisson EC, Bernstein RM, Coppock JS, Davies PG, Doyle DV, Platt PR, Scott DL, Witherington RH, Wojtulewski JA.
    Eur J Rheumatol Inflamm; 1992; 12(2):27-30. PubMed ID: 1364935
    [Abstract] [Full Text] [Related]

  • 22. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [Abstract] [Full Text] [Related]

  • 23. [Clinical results of a multicentral double-blind examination of naproxen compared to indomethacin in chronic rheumatoid arthritis, ankylosing spondylitis, and osteoarthrosis].
    Aeidler H.
    Arzneimittelforschung; 1975 Feb; 25(2A):315-8. PubMed ID: 1096903
    [Abstract] [Full Text] [Related]

  • 24. Naproxen and piroxicam. A comparative trial in rheumatoid arthritis.
    Huskisson EC, Greenwood A.
    Eur J Rheumatol Inflamm; 1983 Feb; 6(3):242-6. PubMed ID: 6239778
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Double-blind evaluation of piroxicam and naproxen following missed dosage in patients with inflammatory arthritis.
    Langley GB, Fowles M, Sirett P, Vlieg M, Wigley RD.
    N Z Med J; 1985 Jun 26; 98(781):490-2. PubMed ID: 3892383
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M.
    Clin Ther; 2009 Aug 26; 31(8):1754-64. PubMed ID: 19808134
    [Abstract] [Full Text] [Related]

  • 33. Double-blind crossover comparison of naproxen and indomethacin in rheumatoid arthritis.
    Desai MM, Shetty RN.
    J Assoc Physicians India; 1977 Oct 26; 25(10):703-7. PubMed ID: 353025
    [No Abstract] [Full Text] [Related]

  • 34. Benoxaprofen administered once a day: determination of optimum dosage schedule.
    Lightfoot RW.
    J Rheumatol Suppl; 1980 Oct 26; 6():61-7. PubMed ID: 6993674
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Comparison of naproxen and piroxicam in rheumatoid arthritis and Bechterew's syndrome. A double-blind parallel multicenter study].
    Myklebust G.
    Tidsskr Nor Laegeforen; 1986 Jun 20; 106(17-18):1485-7. PubMed ID: 3532419
    [No Abstract] [Full Text] [Related]

  • 37. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
    Bensen WG, Zhao SZ, Burke TA, Zabinski RA, Makuch RW, Maurath CJ, Agrawal NM, Geis GS.
    J Rheumatol; 2000 Aug 20; 27(8):1876-83. PubMed ID: 10955327
    [Abstract] [Full Text] [Related]

  • 38. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR, Benson GD, Zinsenheim JR, Schweinle JE.
    Clin Ther; 2006 Feb 20; 28(2):222-35. PubMed ID: 16678643
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.